Professional Documents
Culture Documents
• n Human Embryonic
Stem Cells genetically
engineered and coaxed
to become heart cells
• n Clusters of cells beat
on their own triggered
the unified beating of
rat heart muscle cells
• n Triggered regular
beating when implanted
in guinea pigs
• n Cells responded to
drugs used to slow or
speed up heart rate
• n Use genetic
engineering to
customize the pacing
rate of the cells
Retinal Degeneration:
• n Mice predisposed for
Retinitis Pigmentosa: a
degenerative disease that
destroys retinas
• n Injected bone
marrowderived stem cells into
the back of mouse eyes
during development
• n Dramatically curtailed
retinal degeneration
• n Completely normal
vasculature, improved retinal
tissue and light response
• n Disorders of the retina that
have vascular and neuronal
degeneration: genetic
disorders known collectively
as retinitis pigmentosa
A primer on Human Embryonic Stem Cells
Blastocyst -
from In Vitro Fertilization Clinic
“Blueprint” cells
Inner Cell Mass
(Stem Cells)
Pipette
Stem Cells “Blueprint” cells
A Blastocyst is a hollow ball of cells with a
small clump of stem cells inside
“Blueprint”
Stem Cells
cells
Stem Cells “Blueprint” cells Stem Cells
A Blastocyst is a hollow ball of cells with a To remove the stem cells, the Blastocyst is
small clump of stem cells inside broken open and the stem cells removed with
a pipette(an ultra thin glass tube)
Petri Dish
Stem Cells
Pancreatic
Islet Muscle
Neuron cell
Different chemicals / molecules are added to the stem
cells to make them become specific types of cells.
Somatic Cell Nuclear Transfer or Therapeutic Cloning
Donor Egg Skin Cell
Nucleus Nucleus
(DNA) (DNA)
Needle Needle
Stem Cells
Chemicals and
Growth Factors
Pancreatic
Islet
Blastocyst Neuron
Stem Cells
Dividing cells Muscle cell
The vision for UCI’s Stem Cell
Center:
Stem cell therapies for neurological
disorders
• Brain and spinal cord
injury.
• Stroke.
• Neurodegenerative
diseases
– Parkinson’s Disease
– Huntington’s Disease
– Alzheimer’s Disease
– Multiple Sclerosis
Neurological disorders involve the
loss of particular cell types in the
nervous system
• Brain and spinal cord injury and stroke (loss
of nerve cells and myelin-forming
oligodendrocytes).
• Neurodegenerative diseases
– Parkinson’s Disease (loss of dopamine-containing
nerve cells in the brainstem).
– Huntington’s Disease (loss of nerve cells in the
striatum).
– Alzheimer’s Disease (loss of nerve cells in the
cerebral cortex).
– Multiple Sclerosis (loss of myelin-forming
oligodendrocytes).
– Lou Gerhig’s Disease-ALS (loss of motor neurons
from the spinal cord).
Goal #1: to make stem cells into nerve cells Stem
Blastocyst
Pipette Cells
“Blueprint”
cells
Petri Dish
Stem Cells “Blueprint” cells
Stem Cells
The stem cells are treated with
factors to cause them to differentiate
into particular cell types Stem cells differentiated into neurons
Goal #2: To discover how to make stem cells
integrate into neural circuits.
Nerve cell (neuron) Oligodendrocyte
More research is needed to find the
ways to actually use stem cells for
therapeutic applications.
At the RIRC, a therapy is being developed to
use stem cells to replace myelin-forming cells
Myelinforming cells (oligodendrocytes) die
as a result of spinal cord injury, resulting in
the loss of myelin (insulation) from nerve
fibers.
An important potential therapeutic strategy:
Replace myelinforming cells using stem
cells that differentiate into oligodendrocytes.
Brain Heart
Fat
Bone marrow Cartilage